FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Consumer Health Maximum Strength Comtrex Day/Night Cold & Recall

Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorpheniramine…

Novartis Consumer Health · Lincoln, NE

Risk level
Class III
Reported by FDA
Jan 22, 2014
Recall ID
D-738-2014
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled Maximum Strength Comtrex Day/Night Cold & starting May 15, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-738-2014 on Jan 22, 2014. Reason: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Product description

Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg, Phenylephrine HCL 5mg, packaged in 16 coated caplets daytime formula and 16 coated caplets nighttime formula *includes antihistamine Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2082-32.

Lot numbers, UPCs & expiration codes

Lot # 10116279 exp 05/13 Lot # 10117810 exp 06/13 Lot # 10119274 exp 07/13 Lot # 10121463 exp 07/13

Where it was sold

Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-738-2014
Classification
Class III
Status
Terminated
Recall initiated
May 15, 2013
FDA report date
Jan 22, 2014
Quantity
104,328/32-caplet packages
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-738-2014, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
65181
Address
10401 Hwy 6
Code information
Lot # 10116279 exp 05/13 Lot # 10117810 exp 06/13 Lot # 10119274 exp 07/13 Lot # 10121463 exp 07/13
Postal code
68517-9626
Report date
Jan 22, 2014
Product type
Drugs
Recall number
D-738-2014
Classification
Class III
Recalling firm
Novartis Consumer Health
Product quantity
104,328/32-caplet packages
Termination date
Nov 4, 2014
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBR 10mg, Phenylephrine HCL 5mg, packaged in 16 coated caplets daytime formula and 16 coated caplets nighttime formula *includes antihistamine Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622, NDC 0067-2082-32.
Distribution pattern
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Recall initiation date
May 15, 2013
Initial firm notification
Letter
Center classification date
Jan 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-738-2014, published Jan 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls